Key Study
A histomorphometric comparison of Bio-Oss alone versus Bio-Oss and platelet-derived growth factor for sinus augmentation: a postsurgical assessment
Authors: Stuart J. Froum, Stephen Wallace, Sang-Choon Cho, Edwin Rosenburg, Scott Froum, Robert Schoor, Patrick Mascarenhas, Dennis P. Tarnow, Patricia Corby, Nicolas Elian, Stefan Fickl, John Ricci, Bin Hu, Timothy Bromage, Ismael Khouly
Disclaimer: These results are not guaranteed; individual outcomes may vary depending on patient circumstances. This information is for informational purposes only and may not reflect Geistlich’s official position, opinion, or recommendation. Treatment decisions are made at the physician’s discretion, based on the unique needs of each patient.
GEM 21S® has not been approved by the FDA for use in this indication, and the safety and effectiveness of GEM 21S® for use in this indication has not been established by the FDA.
Disclaimer: These results are not guaranteed; individual outcomes may vary depending on patient circumstances. This information is for informational purposes only and may not reflect Geistlich’s official position, opinion, or recommendation. Treatment decisions are made at the physician’s discretion, based on the unique needs of each patient.
GEM 21S® has not been approved by the FDA for use in this indication, and the safety and effectiveness of GEM 21S® for use in this indication has not been established by the FDA.
Geistlich Bio-Oss®, GEM 21S®